Document is current

Article History

Received: 30 July 2025

Accepted: 13 November 2025

First Online: 25 November 2025

Declarations

:

: Prof. Weiler is a member of the Human Medicines Expert Committee of Swissmedic. The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of an agency or a committee or working party. While the authors used data from VigiBase®, the World Health Organization (WHO) global database of individual case report forms, as a source of information, the conclusions do not represent the opinion of the Uppsala Monitoring Centre (UMC) or the World Health Organization. The remaining authors have no competing interests to declare.

: The study was conducted in accordance with the principles of the Declaration of Helsinki. VigiBase®, the WHO global database of individual case safety reports (ICSRs), is the source of the information; the information comes from a variety of sources, and the probability that the suspected adverse effect is drug related is not the same in all cases; the information does not represent the opinion of the Uppsala Monitoring Centre (UMC) or the World Health Organization (WHO). According to WHO policy and UMC guidelines, reports sent from the WHO Programme for International Drug Monitoring member countries to VigiBase® are anonymized. Identifiable data are not available.